elvanse 70 mg
takeda pharmaceuticals international ag ireland branch - lisdeksamfetamindimesilat - kapsel, hard - 70 mg
anagrelide mylan
mylan pharmaceuticals limited - anagrelide hydrochloride - trombocytemi, essensielt - antineoplastiske midler - anagrelide er indikert for reduksjon av forhøyet platederivert teller i fare viktig thrombocythaemia (et) pasienter som er intolerante til deres nåværende terapi eller som har forhøyet platederivert teller ikke reduseres til et akseptabelt nivå ved deres nåværende terapi. an at-risk patientan at-risk essential thrombocythaemia patient is defined by one or more of the following features:>60 years of age ora platelet count >1,000 x 10⁹/l ora history of thrombo-haemorrhagic events.
aduvanz 50 mg
takeda pharmaceuticals international ag ireland branch - lisdeksamfetamindimesilat - kapsel, hard - 50 mg
aduvanz 30 mg
takeda pharmaceuticals international ag ireland branch - lisdeksamfetamindimesilat - kapsel, hard - 30 mg
aduvanz 70 mg
takeda pharmaceuticals international ag ireland branch - lisdeksamfetamindimesilat - kapsel, hard - 70 mg
simvastatin bluefish 10 mg
bluefish pharmaceuticals ab - simvastatin - tablett, filmdrasjert - 10 mg
simvastatin bluefish 20 mg
bluefish pharmaceuticals ab - simvastatin - tablett, filmdrasjert - 20 mg
simvastatin bluefish 40 mg
bluefish pharmaceuticals ab - simvastatin - tablett, filmdrasjert - 40 mg
simvastatin bluefish 80 mg
bluefish pharmaceuticals ab - simvastatin - tablett, filmdrasjert - 80 mg
topiramat bluefish 200 mg
bluefish pharmaceuticals ab - topiramat - tablett, filmdrasjert - 200 mg